Dopamine Agonists
"Dopamine Agonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that bind to and activate dopamine receptors.
| Descriptor ID |
D018491
|
| MeSH Number(s) |
D27.505.519.625.150.151 D27.505.696.577.150.151
|
| Concept/Terms |
Dopamine Agonists- Dopamine Agonists
- Agonists, Dopamine
- Receptor Agonists, Dopamine
- Dopamine Receptor Agonist
- Agonist, Dopamine Receptor
- Receptor Agonist, Dopamine
- Dopamine Receptor Agonists
- Dopaminergic Agonists
- Agonists, Dopaminergic
- Dopaminergic Agonist
- Agonist, Dopaminergic
- Agonists, Dopamine Receptor
- Dopamine Agonist
- Agonist, Dopamine
|
Below are MeSH descriptors whose meaning is more general than "Dopamine Agonists".
Below are MeSH descriptors whose meaning is more specific than "Dopamine Agonists".
This graph shows the total number of publications written about "Dopamine Agonists" by people in UAMS Profiles by year, and whether "Dopamine Agonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2024 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 1996 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dopamine Agonists" by people in Profiles over the past ten years.
-
Hiranita T, Soto PL, Katz JL. Dopamine D1-Like Receptor-Mediated Insurmountable Blockade of the Reinforcing Effects of Cocaine in Rats. J Pharmacol Exp Ther. 2024 Nov 19; 391(3):415-429.
-
Gupta HV, Lyons KE, Pahwa R. Old Drugs, New Delivery Systems in Parkinson's Disease. Drugs Aging. 2019 09; 36(9):807-821.
-
Patel S, Garcia X, Mohammad ME, Yu XX, Vlastaris K, O'Donnell K, Sutton K, Fernandez HH. Dopamine agonist withdrawal syndrome (DAWS) in a tertiary Parkinson disease treatment center. J Neurol Sci. 2017 Aug 15; 379:308-311.